Loading...
Raltegravir
India Pharmaceutical Trade Intelligence
Who Supplies Raltegravir to India from NETHERLANDS
India's raltegravir imports from NETHERLANDS total $42.1K across 10 shipments from 3 foreign suppliers. BMCLINICAL BV leads with $28.7K in import value; the top 5 suppliers together control 100.0% of this origin. Leading Indian buyers include MYLAN LABORATORIES LIMITED. This corridor reflects India's pharmaceutical import demand for raltegravir — a concentrated sourcing relationship with select suppliers from NETHERLANDS.
Top foreign suppliers (NETHERLANDS) — Ranked by import value
BMCLINICAL BV is the leading Raltegravir supplier from NETHERLANDS to India, with import value of $28.7K across 7 shipments. The top 5 suppliers — BMCLINICAL BV, NEWLIFE BIOPHARMA LIMITED, CORIPHARMA EHF — collectively account for 100.0% of total import value from this origin.
Top foreign suppliers (NETHERLANDS)
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | BMCLINICAL BV | $28.7K | 7 | 68.1% |
| 2 | NEWLIFE BIOPHARMA LIMITED | $7.5K | 1 | 17.7% |
| 3 | CORIPHARMA EHF | $6.0K | 2 | 14.1% |
Showing top 3 of 3 foreign suppliers · Indian Customs (DGFT) · TransData Nexus
Top Indian buyers (importing from NETHERLANDS)
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | MYLAN LABORATORIES LIMITED | $24.2K | 6 | 57.5% |
| 2 | AUROBINDO PHARMA LIMITED | $7.5K | 1 | 17.7% |
| 3 | VEEDA CLINICAL RESEARCH LIMITED | $6.0K | 2 | 14.1% |
| 4 | AIZANT DRUG RESEARCH SOLUTIONS PRIVATE LIMITED | $4.5K | 1 | 10.7% |
Import Statistics
- Import Value
- $42.1K
- Shipments
- 10
- Foreign Suppliers
- 3
- Indian Buyers
- 4
- Avg. Shipment
- $4.2K
Other Raltegravir Import Origins
Related Analysis
Frequently Asked Questions — Raltegravir Imports from NETHERLANDS
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
QWho are the top Raltegravir suppliers from NETHERLANDS to India?
The top Raltegravir suppliers from NETHERLANDS to India include BMCLINICAL BV, NEWLIFE BIOPHARMA LIMITED, CORIPHARMA EHF. The leading supplier is BMCLINICAL BV with import value of $28.7K USD across 7 shipments. India imported Raltegravir worth $42.1K USD from NETHERLANDS in total across 10 shipments.
QHow much Raltegravir does India import from NETHERLANDS?
India imported Raltegravir worth $42.1K USD from NETHERLANDS across 10 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
QWho are the main Indian buyers of Raltegravir from NETHERLANDS?
The main Indian buyers of Raltegravir sourced from NETHERLANDS include MYLAN LABORATORIES LIMITED, AUROBINDO PHARMA LIMITED, VEEDA CLINICAL RESEARCH LIMITED. The largest buyer is MYLAN LABORATORIES LIMITED with $24.2K in imports across 6 shipments.
QWhat is the total value of Raltegravir imports from NETHERLANDS to India?
The total value of Raltegravir imports from NETHERLANDS to India is $42.1K USD, across 10 shipments and 3 foreign suppliers. Data source: Indian Customs (DGFT).
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
SS
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: NETHERLANDS to India pharmaceutical import trade corridor identified from Indian Customs (DGFT) shipping bill records for Raltegravir.
- 2.Supplier/Buyer Matching: 3 foreign suppliers from NETHERLANDS and 4 Indian buyers identified using company name normalization across customs records.
- 3.Value Aggregation: Total import value of $42.1K aggregated from 10 verified shipping bill records. All values reported in FOB USD as recorded by Indian Customs.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
10 Verified Shipments
3 suppliers, 4 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists